MyFinsight
Home
Blog
About
Back
Income Statement
Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc. (SER)
source: myfinsight.com
Net loss
attributable to serina...
-$6,356,000
(1.43%↑ Y/Y)
Change in fair value of
tranche liability
$347,000
Other income, net
$234,000
(244.12%↑ Y/Y)
Change in fair value of
warrants
-$50,000
(-105.23%↓ Y/Y)
Net loss
-$6,356,000
(1.64%↑ Y/Y)
Total other income
(expense), net
$428,000
(147.71%↑ Y/Y)
Interest expense
$203,000
(2155.56%↑ Y/Y)
Loss from operations
-$6,784,000
(-21.90%↓ Y/Y)
Total operating
expenses
$6,784,000
(19.12%↑ Y/Y)
Research and development
$3,816,000
(21.07%↑ Y/Y)
General and
administrative
$2,968,000
(16.71%↑ Y/Y)
Back